Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated May 24, 2024, titled "Press Release for Grant of USFDA Approval".
Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated May 24, 2024, titled "Press Release for Grant of USFDA Approval".